Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study Measuring the Safety, Immunogenicity and Lot Consistency of Cell Derived Influenza Vaccine

This study has been completed.
Quintiles, Inc.
Information provided by (Responsible Party):
Abbott ( Abbott Biologicals ) Identifier:
First received: October 20, 2009
Last updated: August 25, 2011
Last verified: August 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2010
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)